Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts. Show more

Location: 930 Winter Street, Waltham, MA, 02451, United States | Website: https://www.aerovatetx.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

77.68M

52 Wk Range

$2.63 - $884.98

Previous Close

$9.90

Open

$9.88

Volume

156,093

Day Range

$9.68 - $10.36

Enterprise Value

1.782M

Cash

76.21M

Avg Qtr Burn

-12.48M

Insider Ownership

0.02%

Institutional Own.

-

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.